“have been fast and this is his rep

“have been fast and this is his reply: I am sorry but we do not speak Spanish, I will try to reply you in Inglés. Let me know if this is fine for you or I will try in Italian. With regard to the remedy for alopecia Studied by Professor Brotzu, in collaboration With the Researchers at the University of Cagliari for the part of formulation development, Fidia That points out it with scientific discovery is a very interesting potential, Which the prompted the company to acquire intellectual property and to work for it to Become real opportunity for all Patients Who are afflicted by esta problem. It is important now to Implement the usual development path to Ensure first That the efficacy and safety of the remedy are in compliance With the requirements of the latest regulations governing the production of products for the health of people, and Then define the best solution to make it available to Patients. Fidia AIMS to start the clinical study in March 2016, According to a defined protocol and Whose formulation will Then have to be developed industrially. We are conscious THEREFORE That it is premature to set a date for the product launch, we hope it will be in 2017 based on the study results. Anyhow as you are extremely interested in this topic, I would Suggest you get in Contact with Professor Brotzu [e-mail] , Who Will Evaluate a possible Involvement in His future tests. Best regards”

結果 (中文) 1:

"加快了步伐，这是他的回答: 很抱歉，但我们不会说西班牙语吗，我会尽量回复你 Inglés。让我知道是否这是适合你或我会尽量在意大利。关于脱发研究的教授 Brotzu 的协作与研究员卡利亚里大学的配方研制，部分弥补指出它与科学发现的 Fidia 是一个非常有趣的潜力，这促使公司获得知识产权，并为它成为真正的机会，为所有病人谁工作被 esta 问题所困扰。它是人的重要的现在执行常规的发展路线，首先确保的疗效和安全性的补救达到生产的产品，为健康，最新法规的要求，然后定义向病人提供最佳的解决方案。Fidia 旨在启动 2016 年 3 月，根据定义的协议，其配方然后将不得不工业开发的临床研究。我们都是为时过早的产品推出日期设置的意识因此，我们希望它将在 2017 年基于研究结果。Anyhow as you are extremely interested in this topic, I would Suggest you get in Contact with Professor Brotzu [e-mail] , Who Will Evaluate a possible Involvement in His future tests.最好的问候"

結果 (中文) 3:

“已经快，这是他的回答：对不起，我们不说西班牙语，我会尽量在所有éS.回复你让我知道这对你或我好会在意大利。对于脱发的布罗楚教授研究的药物，与在制定发展的部分，卡利亚里大学的研究人员合作，FIDIA，指出它与科学的发现是一个非常有趣的潜力，这促使公司获得的知识产权，它成为所有患者的基础问题折磨的真正机会的工作。重要的是，现在要实施通常的发展道路，以确保有效和安全的补救措施，以符合最新的规定，为人民的健康生产的最新法规的要求，然后定义了最佳的解决方案，使其提供给病人。FIDIA旨在2016三月开始临床研究，根据定义的协议的制定就必须发展工业。因此，我们是有意识的，因为它是提前设定日期的产品推出，我们希望它将在2017的基础上的研究结果。无论如何，你在这个话题非常感兴趣，我建议你在布罗楚[e-mail]教授联系，他将评估他的未来的测试可能参与。最好的问候